DAVID M MOTT Insider Trading $EPZM Epizyme, Inc.
Get free email notifications about insider trading for DAVID M MOTT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID M MOTT. DAVID M MOTT is Vice Chairman and CEO in MEDIMMUNE INC /DE ($MEDI) and Director in NOVAVAX INC ($NVAX) and 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and Director in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and Director in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and Director in TESARO, Inc. ($TSRO) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Epizyme, Inc. ($EPZM) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in IMARA Inc. ($IMRA) and 10% Owner in Elastic N.V. ($ESTC) and Director in Nightstar Therapeutics plc ($NITE) and 10% Owner in Surface Oncology, Inc. ($SURF) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM).
DAVID M MOTT in Epizyme, Inc.
Trading Symbol: EPZMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 153,627 shares
Current Value: $1,851,205
Latest Transaction: Apr 01 2021
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID M MOTT in Epizyme, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ADAP, APPN, ABIO, ARDX, AVEO, CRCM, CASC, CERC, ESTC, EPZM, GNCA, IMRA, ILIU, MEDI, MRSN, MIRM, MULE, NITE, NVAX, RARX, RGLS, RYTM, ROKA, SURF, SYBX, TSRO, TCON, TRVI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 01 2021 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Grant | A | 8.71 | 2,727 | 23,752 | 153,627 | 150.9 K to 153.6 K (+1.81 %) |
Jan 05 2021 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Grant | A | 10.86 | 2,158 | 23,436 | 88,183 | 86 K to 88.2 K (+2.51 %) |
Oct 01 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Grant | A | 11.93 | 1,965 | 23,442 | 86,025 | 84.1 K to 86 K (+2.34 %) |
Sep 28 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 12.66 | 50,000 | 633,000 | 50,000 | |
Jul 01 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Grant | A | 16.06 | 1,459 | 23,432 | 84,060 | 82.6 K to 84.1 K (+1.77 %) |
Jun 26 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 16.03 | 62,019 | 994,165 | 82,601 | 20.6 K to 82.6 K (+301.33 %) |
Jun 22 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 67,662 | 0 | 106,959 | 39.3 K to 107 K (+172.18 %) |
Jun 02 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
Apr 02 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Grant | A | 15.51 | 1,512 | 23,451 | 20,582 | 19.1 K to 20.6 K (+7.93 %) |
Oct 02 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Grant | A | 10.32 | 2,271 | 23,437 | 18,118 | 15.8 K to 18.1 K (+14.33 %) |
Jun 28 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | S | 12.43 | 52,473 | 652,134 | 0 | 52.5 K to 0 (-100.00 %) |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | S | 12.85 | 52,472 | 674,176 | 52,473 | 104.9 K to 52.5 K (-50.00 %) |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | S | 13.31 | 52,472 | 698,649 | 104,945 | 157.4 K to 104.9 K (-33.33 %) |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 157,417 | 0 | 157,417 | 0 to 157.4 K |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 38,646 | 0 | 39,297 | 651 to 39.3 K (+5,936.41 %) |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 767,500 | 0 | 0 | 767.5 K to 0 (-100.00 %) |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 767,500 | 0 | 767,500 | 0 to 767.5 K |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 2,500,000 | 0 | 3,971,018 | 6.5 M to 4 M (-38.63 %) |
Jun 07 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 13.74 | 17,633 | 242,277 | 17,633 | |
Jun 07 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Grant | A | 12.39 | 1,891 | 23,429 | 13,979 | 12.1 K to 14 K (+15.64 %) |
Oct 05 2018 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 9.00 | 416,667 | 3,750,003 | 6,471,018 | 6.1 M to 6.5 M (+6.88 %) |
Jul 02 2018 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Grant | A | 13.55 | 6,088 | 82,492 | 12,088 | 6 K to 12.1 K (+101.47 %) |
May 31 2018 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 17.00 | 12,500 | 212,500 | 12,500 | |
Sep 18 2017 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 15.25 | 200,000 | 3,050,000 | 6,054,351 | 5.9 M to 6.1 M (+3.42 %) |
Jun 26 2017 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 13.65 | 12,500 | 170,625 | 12,500 | |
Jul 06 2016 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Grant | A | 10.33 | 6,000 | 61,980 | 6,000 | 0 to 6 K |
May 23 2016 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 9.33 | 12,500 | 116,625 | 12,500 | |
Jan 12 2016 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 5,854,351 | 4.7 M to 5.9 M (+23.43 %) |
Jul 10 2015 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 22.78 | 7,333 | 167,046 | 7,333 |
Page: 1